Argyle Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.82M | Hold |
19,371
| – | – | 2.21% | 9 |
|
|
2025
Q4 | $6.34M | Hold |
19,371
| – | – | 2.12% | 10 |
|
|
2025
Q3 | $5.47M | Hold |
19,371
| – | – | 1.89% | 10 |
|
|
2025
Q2 | $5.41M | Sell |
19,371
-200
| -1% | -$56.7K | 1.96% | 10 |
|
|
2025
Q1 | $6.1M | Buy |
19,571
+185
| +1% | +$54.6K | 2.26% | 5 |
|
|
2024
Q4 | $5.05M | Buy |
19,386
+385
| +2% | +$114K | 1.99% | 8 |
|
|
2024
Q3 | $6.12M | Sell |
19,001
-770
| -4% | -$252K | 2.44% | 5 |
|
|
2024
Q2 | $6.18M | Sell |
19,771
-2,030
| -9% | -$596K | 2.54% | 5 |
|
|
2024
Q1 | $6.2M | Sell |
21,801
-770
| -3% | -$225K | 2.4% | 7 |
|
|
2023
Q4 | $6.5M | Sell |
22,571
-3,175
| -12% | -$865K | 2.69% | 5 |
|
|
2023
Q3 | $6.92M | Buy |
25,746
+750
| +3% | +$187K | 2.53% | 5 |
|
|
2023
Q2 | $5.55M | Sell |
24,996
-1,460
| -6% | -$339K | 2% | 8 |
|
|
2023
Q1 | $6.4M | Buy |
26,456
+50
| +0.2% | +$12.3K | 2.25% | 6 |
|
|
2022
Q4 | $6.94M | Sell |
26,406
-248
| -0.9% | -$66.5K | 2.38% | 7 |
|
|
2022
Q3 | $6.01M | Hold |
26,654
| – | – | 2.34% | 6 |
|
|
2022
Q2 | $6.49M | Hold |
26,654
| – | – | 2.33% | 5 |
|
|
2022
Q1 | $6.45M | Sell |
26,654
-800
| -3% | -$184K | 2.1% | 6 |
|
|
2021
Q4 | $6.18M | Sell |
27,454
-500
| -2% | -$106K | 1.93% | 10 |
|
|
2021
Q3 | $5.94M | Sell |
27,954
-150
| -0.5% | -$34.5K | 1.97% | 9 |
|
|
2021
Q2 | $6.85M | Buy |
28,104
+200
| +0.7% | +$49.2K | 2.21% | 3 |
|
|
2021
Q1 | $6.94M | Hold |
27,904
| – | – | 2.34% | 3 |
|
|
2020
Q4 | $6.42M | Sell |
27,904
-240
| -0.9% | -$55.3K | 2.39% | 3 |
|
|
2020
Q3 | $7.15M | Sell |
28,144
-200
| -0.7% | -$49.5K | 2.93% | 2 |
|
|
2020
Q2 | $6.68M | Sell |
28,344
-300
| -1% | -$68.4K | 2.8% | 4 |
|
|
2020
Q1 | $5.81M | Hold |
28,644
| – | – | 2.74% | 4 |
|
|
2019
Q4 | $6.91M | Sell |
28,644
-425
| -1% | -$93.7K | 2.45% | 4 |
|
|
2019
Q3 | $5.63M | Sell |
29,069
-50
| -0.2% | -$9.6K | 2.13% | 5 |
|
|
2019
Q2 | $5.37M | Hold |
29,119
| – | – | 2.04% | 5 |
|
|
2019
Q1 | $5.53M | Buy |
29,119
+150
| +0.5% | +$28.6K | 2.13% | 6 |
|
|
2018
Q4 | $5.64M | Sell |
28,969
-725
| -2% | -$141K | 2.39% | 5 |
|
|
2018
Q3 | $6.16M | Hold |
29,694
| – | – | 2.3% | 5 |
|
|
2018
Q2 | $5.48M | Sell |
29,694
-150
| -0.5% | -$26.5K | 2.17% | 7 |
|
|
2018
Q1 | $5.09M | Sell |
29,844
-750
| -2% | -$138K | 2.02% | 7 |
|
|
2017
Q4 | $5.32M | Sell |
30,594
-90
| -0.3% | -$15.9K | 1.99% | 8 |
|
|
2017
Q3 | $5.72M | Hold |
30,684
| – | – | 2.25% | 4 |
|
|
2017
Q2 | $5.29M | Buy |
30,684
+100
| +0.3% | +$16.3K | 2.15% | 4 |
|
|
2017
Q1 | $5.02M | Buy |
30,584
+168
| +0.6% | +$27.9K | 2.05% | 4 |
|
|
2016
Q4 | $4.45M | Buy |
30,416
+80
| +0.3% | +$12K | 1.89% | 11 |
|
|
2016
Q3 | $5.06M | Sell |
30,336
-750
| -2% | -$127K | 2.19% | 5 |
|
|
2016
Q2 | $4.73M | Buy |
31,086
+400
| +1% | +$62.2K | 2.01% | 10 |
|
|
2016
Q1 | $4.6M | Sell |
30,686
-500
| -2% | -$74.3K | 2.09% | 10 |
|
|
2015
Q4 | $5.06M | Sell |
31,186
-100
| -0.3% | -$15.7K | 2.33% | 6 |
|
|
2015
Q3 | $4.33M | Sell |
31,286
-850
| -3% | -$134K | 2.11% | 7 |
|
|
2015
Q2 | $4.93M | Sell |
32,136
-2,240
| -7% | -$359K | 2.26% | 5 |
|
|
2015
Q1 | $5.5M | Sell |
34,376
-1,113
| -3% | -$175K | 2.46% | 4 |
|
|
2014
Q4 | $5.65M | Sell |
35,489
-3,560
| -9% | -$555K | 2.48% | 3 |
|
|
2014
Q3 | $5.49M | Sell |
39,049
-400
| -1% | -$52.2K | 2.53% | 3 |
|
|
2014
Q2 | $4.67M | Hold |
39,449
| – | – | 2.18% | 5 |
|
|
2014
Q1 | $4.87M | Sell |
39,449
-800
| -2% | -$97K | 2.39% | 6 |
|
|
2013
Q4 | $4.59M | Hold |
40,249
| – | – | 2.31% | 6 |
|
|
2013
Q3 | $4.5M | Sell |
40,249
-1,050
| -3% | -$114K | 2.47% | 4 |
|
|
2013
Q2 | $4.08M | Buy |
+41,299
| New | +$4.29M | 2.34% | 8 |
|
Other funds holding AMGN
VCM
VPM
Argyle Capital Management's AMGN Position: Q1 2026 in Review
Argyle Capital Management held its Amgen (AMGN) position steady in Q1 2026 at 19,371 shares worth $6.82M. The position accounts for 2.21% of the portfolio, ranked #9.
Argyle Capital Management first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.15M in Q3 2020. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Argyle Capital Management held 19,371 shares of Amgen worth $6.82M as of Q1 2026.
- Argyle Capital Management left its Amgen share count unchanged in Q1 2026.
- Amgen made up 2.21% of Argyle Capital Management's portfolio in Q1 2026, its #9 holding.
- Argyle Capital Management first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Argyle Capital Management's Amgen position peaked at $7.15M in Q3 2020.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Argyle Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.